References and Notes
1
Cave A.
Chaboche C.
Figadère B.
Harmange JC.
Laurens AA.
Peyrat JF.
Pichon M.
Szlosek M.
Cotte-Laffite J.
Quero AM.
Eur. J. Med. Chem.
1997,
617
2
Reiser MJ.
Kozlowski JF.
Wood KV.
McLaughlin JL.
Tetrahedron Lett.
1991,
32:
1137
3a
Prasad KR.
Anbarasan P.
Tetrahedron: Asymmetry
2006,
17:
2465
3b
Popsavin V.
Krstić I.
Popsavin M.
Srećo B.
Benedeković G.
Kojić V.
Bogdanović G.
Tetrahedron
2006,
62:
11044
3c
Popsavin V.
Srećo B.
Krstić I.
Popsavin M.
Kojić V.
Bogdanović G.
Eur. J. Med. Chem.
2006,
1217
3d
Dhotare B.
Chattopadhyay A.
Tetrahedron Lett.
2005,
46:
3103
3e
Quinn KJ.
Isaacs AK.
Arvary RA.
Org. Lett.
2004,
6:
4143
3f
Yoshimitsu T.
Makino T.
Nagaoka H.
J. Org. Chem.
2003,
68:
7548
3g
Bernard AM.
Frongia A.
Piras PP.
Secci F.
Org. Lett.
2003,
5:
2923
3h
Popsavin V.
Krstić I.
Popsavin M.
Tetrahedron Lett.
2003,
44:
8897
3i
Raghavan S.
Joseph SC.
Tetrahedron: Asymmetry
2003,
14:
101
3j
Carda M.
Rodriguez S.
Gonzalez F.
Castillo E.
Villanueva A.
Marco JA.
Eur. J. Org. Chem.
2002,
2649
3k
Chandrasekhar M.
Chandra KL.
Singh VK.
Tetrahedron Lett.
2002,
43:
2773
3l
Konno H.
Hiura N.
Yanura M.
Heterocycles
2002,
57:
1793
3m
Baylon C.
Prestat G.
Heck MP.
Mioskowski C.
Tetrahedron Lett.
2000,
41:
3833
3n
Trost BM.
Rhee YH.
J. Am. Chem. Soc.
1999,
121:
11680
3o
Solladié G.
Hanquet G.
Izzo I.
Crumbie R.
Tetrahedron Lett.
1999,
40:
3071
3p
Couladouros EA.
Mihou AP.
Tetrahedron Lett.
1999,
40:
4861
3q
Marshall JA.
Welmaker GS.
J. Org. Chem.
1994,
59:
4122
3r
Wang Z.-M.
Zhang X.-L.
Sharpless KB.
Tetrahedron Lett.
1992,
33:
6407
3s
Scholz G.
Tochtermann W.
Tetrahedron Lett.
1991,
32:
5535
3t
Kotsuki H.
Miyazaki A.
Ochi M.
Slims JJ.
Bull. Chem. Soc. Jpn.
1991,
64:
721
3u
Wright AE.
Schafer M.
Midland S.
Munnecke DE.
Slims JJ.
Tetrahedron Lett.
1989,
30:
5699
4a
Smith CJ.
Abbanat D.
Bernan VS.
Maiese WM.
Greenstein M.
Jompa J.
Tahir A.
Ireland CM.
J. Nat. Prod.
2000,
63:
142
4b
Brauers G.
Edrada RA.
Ebel R.
Proksch P.
Wray V.
Berg A.
Gräfe U.
Schächtele C.
Totzke F.
Finkenzeller G.
Marme D.
Kraus J.
Munchbach M.
Michel M.
Bringmann G.
Schaumann K.
J. Nat. Prod.
2000,
63:
739
4c
Gestner S.
Cohen N.
Ilan M.
Yarden O.
Carmeli S.
J. Nat. Prod.
2005,
68:
1350
4d
Dai H.-Q.
Kang Q.-J.
Li G.-H.
Shen Y.-M.
Helv. Chim. Acta
2006,
89:
527
5a
Franck X.
Vaz Araujo ME.
Jullian JC.
Hocquemiller R.
Figadère B.
Tetrahedron Lett.
2001,
42:
2801
5b
Austin KAB.
Banwell MG.
Loong DTJ.
Rae D.
Willis AC.
Org. Biomol. Chem.
2005,
3:
1081
5c
Pandey SK.
Kumar P.
Tetrahedron Lett.
2005,
46:
6625
5d
Sharma GVM.
Reddy JJ.
Reddy KL.
Tetrahedron Lett.
2006,
47:
6531
6
Sharma GVM.
Reddy JJ.
Reddy KL.
Tetrahedron Lett.
2006,
47:
6537
7
Ferrié L.
Amans D.
Reymond S.
Bellosta V.
Capdevielle P.
Cossy J.
J. Organomet. Chem.
2006,
691:
5456
8a
Kolb HC.
VanNieuwenhze MS.
Sharpless KB.
Chem. Rev.
1994,
94:
2483
8b
Xu D.
Crispino GA.
Sharpless KB.
J. Am. Chem. Soc.
1992,
114:
1510
8c
Hermitage SA.
Murphy A.
Nielsen P.
Roberts SM.
Tetrahedron
1998,
54:
13185
8d
Zaitsev AB.
Adolfsson H.
Synthesis
2006,
1725
9a
Corey EJ.
Fuchs PL.
Tetrahedron Lett.
1972,
36:
3769
9b
Bialy L.
Waldmann H.
Chem. Eur. J.
2004,
10:
2759
10 Compound 5 (prepared in >10 mmol scale): IR (neat): 3000-2800, 2200, 1650, 1593, 1427, 1339, 1167,1095, 995, 953, 832, 789 cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.39 (dd, J = 15.0, 11.3 Hz, 1 H), 6.47 (t, J = 11.3 Hz, 1 H), 6.05 (d, J = 11.3 Hz, 1 H), 6.01 (dq, J = 15.1, 6.9 Hz, 1 H), 3.66 (s, 3 H), 3.20 (s, 3 H), 1.84 (d, J = 6.9 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 167.4 (br s), 143.1 (d), 139.0 (d), 128.6 (d), 113.5 (d), 61.5 (q), 32.1 (br q), 18.5 (q). MS (EI): m/z (%) = 155 (21) [M+•], 124 (2) [M - OMe+], 95 (100) [M - NMeOMe+], 67 (60) [95 - CO+].
11 Modified AD-mix: OsO4 (2 mol%), (DHQ)2PHAL for AD-mix α (4 mol%), or (DHQD)2PHAL for AD-mix β (4 mol%), MeSO2NH2 (1 equiv), K3Fe(CN)6 (3 equiv), K2CO3 (3 equiv), t-BuOH-H2O, see ref. 8c.
12 The ee of lactone 7 was determined by chiral supercritic fluid chromatography (SFC) [Chiralcel OD-H, CO2 100 bar, 5 mL/min, 7% i-PrOH, λ = 220 nm, t
R (S,S) = 5.87 min, t
R (R,R) = 6.50 min].
13 (-)-Muricatacin (prepared in <1 mmol scale): mp 69-72 °C (synthetic product3j mp 68-70 °C); [α]D
20 -19.6 (c 1.0, CHCl3) {isolated natural product5 [α]D
20 -16.1; reported synthetic product3j [α]D
23 -19.5 (c 2.1, CHCl3)}; IR (neat): 3396, 3000-2800, 1727, 1470, 1176 cm-1. 1H NMR (400 MHz, CDCl3): δ = 4.41 (td, J = 7.5, 4.6 Hz, 1 H), 3.57 (m, 1 H), 2.62 (ddd, J = 17.8, 9.9, 5.0 Hz, 1 H), 2.54 (ddd, J = 17.8, 9.5, 9.0 Hz, 1 H), 2.30-2.20 (m, 1 H), 2.17-2.06 (m, 1 H), 1.88 (m, 1 H, OH), 1.60-1.18 (m, 22 H), 0.88 (t, J = 6.7 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 177.1 (s), 82.9 (d), 73.7 (d), 33.0 (t), 31.9 (t), 29.6 (t), 29.6 (t), 29.6 (t), 29.5 (t), 29.5 (t), 29.5 (t), 29.3 (t), 28.9 (t), 25.4 (t), 24.1 (t), 22.7 (t), 14.1 (q). MS (EI): m/z (%) = 283 (1) [M - H+], 207 (9), 97 (14), 86 (100), 69 (17), 55 (17). ESI-HRMS: m/z calcd for C17H32O3 + Na+: 307.2244; found: 307.2239.
14 (-)-iso-Cladospolide B (prepared in <1 mmol scale): [α]D
20 -61.6 (c 0.50, MeOH); {isolated natural product4c [α]D
28 -61.0 (c 16.6, MeOH)}. IR (neat): 3487, 3000-2800, 1745, 1462, 1329, 1165, 1097, 1042, 828 cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.46 (dd, J = 5.8, 1.5 Hz, 1 H), 6.18 (dd, J = 5.8, 2.0 Hz, 1 H), 4.99 (dtapp, J = 4.5, 1.8 Hz, 1 H), 3.86-3.66 (m, 2 H), 2.21-1.81 (m, 2 H, OH), 1.66-1.26 (m, 10 H), 1.18 (d, J = 6.2 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 172.9 (s), 153.8 (d), 122.7 (d), 86.2 (d), 71.7 (d), 68.0 (d), 39.0 (t), 33.0 (t), 29.3 (t), 25.5 (t), 25.4 (t), 23.5 (q). ESI-HRMS (ESI): m/z calcd for C12H20O4 + Na+: 251.1248; found: 251.1253.